| scholarly article | Q13442814 |
| P50 | author | Bruno Sainz | Q87622826 |
| P2093 | author name string | William P Halford | |
| P2860 | cites work | IDU therapy of herpes simplex | Q78946264 |
| Effect of Acycloguanosine Treatment on Acute and Latent Herpes Simplex Infections in Mice | Q28327450 | ||
| Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes | Q33644596 | ||
| Role for gamma interferon in control of herpes simplex virus type 1 reactivation. | Q33645342 | ||
| Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study. | Q33693860 | ||
| The second-site mutation in the herpes simplex virus recombinants lacking the gamma134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2alpha | Q33783719 | ||
| Herpes simplex virus ICP0 mutants are hypersensitive to interferon | Q33798242 | ||
| Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo | Q33806643 | ||
| Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in mice. | Q33808288 | ||
| Gamma interferon (IFN-gamma) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-gamma ligand null-mutant mice | Q33814630 | ||
| ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells | Q33842593 | ||
| Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons | Q33849352 | ||
| Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. | Q33894781 | ||
| Herpes simplex virus: the importance of asymptomatic shedding | Q33905770 | ||
| Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits | Q33982508 | ||
| Inhibition of hepatitis B virus replication by interferon requires proteasome activity | Q34334519 | ||
| The inherent quantitative capacity of the reverse transcription-polymerase chain reaction | Q34487564 | ||
| Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent | Q34999871 | ||
| Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice | Q35196025 | ||
| Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene | Q35760833 | ||
| Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1 | Q35844818 | ||
| Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection | Q35853529 | ||
| Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons | Q36231298 | ||
| Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration | Q36365733 | ||
| T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis | Q36377310 | ||
| CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons | Q36404348 | ||
| Interferon as an Agent Against Herpes Simplex Virus | Q36612275 | ||
| Herpetic stromal keratitis in the reconstituted scid mouse model | Q36648038 | ||
| Quantitative analysis of polymerase chain reaction products by dot blot | Q36824821 | ||
| Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons | Q36912127 | ||
| Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment | Q37364727 | ||
| Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes | Q37380356 | ||
| Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication | Q39682468 | ||
| Development of antiviral therapy with alpha interferons: promises, false hopes and accomplishments | Q40520328 | ||
| Herpes simplex viremia: report of eight pediatric cases and review of the literature | Q40661509 | ||
| Epidemiology of genital herpes. | Q40690587 | ||
| The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta | Q40745643 | ||
| The molecular cell biology of interferon-gamma and its receptor | Q40898233 | ||
| Herpesvirus infections in persons infected with human immunodeficiency virus | Q40938423 | ||
| Reoviruses and the interferon system. | Q41040736 | ||
| Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1. | Q41074976 | ||
| Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. | Q41158662 | ||
| Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma). | Q41459277 | ||
| Oral shedding of herpes simplex virus type 1: a review | Q41673268 | ||
| Tipping the scales of herpes simplex virus reactivation: the important responses are local | Q41740276 | ||
| Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons | Q43704029 | ||
| Expression of human and macaque type I IFN transgenes interferes with HSV-1 replication at the transcriptional and translational levels: IFN-beta is more potent than IFN-alpha 2. | Q43908614 | ||
| Recombinant HuIFN-gamma prevents herpes simplex keratitis in African green monkeys: demonstration of synergism with recombinant HuIFN-alpha 2. | Q44246212 | ||
| Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. | Q44270966 | ||
| Effect of exogenous interferon on herpetic keratitis in rabbits and monkeys. | Q44717944 | ||
| Synergistic activities of type I (α, β) and type II (γ) murine interferons | Q45249072 | ||
| RELATIONSHIP BETWEEN THE ENVELOPE AND THE INFECTIVITY OF HERPES SIMPLEX VIRUS. | Q45714924 | ||
| The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice | Q45747997 | ||
| Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis | Q45750060 | ||
| Immune cell infiltration in corneas of mice with recurrent herpes simplex virus disease | Q45771219 | ||
| Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes | Q45771892 | ||
| Role of NK cells in protection of mice against herpes simplex virus-1 infection. | Q45829237 | ||
| Enhanced inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts by combinations of interferon-alpha and -gamma | Q45876703 | ||
| In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis | Q48179891 | ||
| The essential prerequisites for quantitative RT-PCR | Q78203808 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 11541-11550 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. | |
| P478 | volume | 76 |
| Q42215415 | A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses |
| Q58746172 | Abortigenic but Not Neurotropic Equine Herpes Virus 1 Modulates the Interferon Antiviral Defense |
| Q41665315 | Abrogation of the interferon response promotes more efficient human cytomegalovirus replication |
| Q35259878 | Activation and evasion of innate antiviral immunity by herpes simplex virus |
| Q28590087 | An image-based genetic assay identifies genes in T1D susceptibility loci controlling cellular antiviral immunity in mouse |
| Q35802799 | Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1. |
| Q42246861 | Aurintricarboxylic acid increases yield of HSV-1 vectors |
| Q37355864 | Bacterial artificial chromosome derived simian varicella virus is pathogenic in vivo |
| Q34350245 | Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells. |
| Q36474223 | Bioluminescence Imaging Reveals Systemic Dissemination of Herpes Simplex Virus Type 1 in the Absence of Interferon Receptors |
| Q57473488 | Bowman‒Birk Inhibitor Suppresses Herpes Simplex Virus Type 2 Infection of Human Cervical Epithelial Cells |
| Q36597915 | C-terminal trans-activation sub-region of VP16 is uniquely required for forskolin-induced herpes simplex virus type 1 reactivation from quiescently infected-PC12 cells but not for replication in neuronally differentiated-PC12 cells |
| Q35024336 | Characterization of a potent refractory state and persistence of herpes simplex virus 1 in cell culture |
| Q34142890 | Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms |
| Q37135783 | Constitutive IFNα/β signaling maintains expression of signaling intermediaries for efficient cytokine responses |
| Q26852421 | Cytokine synergy: an underappreciated contributor to innate anti-viral immunity |
| Q33767313 | Distinctive roles for 2',5'-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-beta. |
| Q100729297 | Divergent SARS-CoV-2-specific T and B cell responses in severe but not mild COVID-19 patients |
| Q45365980 | Effects of interferon on immediate-early mRNA and protein levels in sensory neuronal cells infected with herpes simplex virus type 1 or pseudorabies virus |
| Q33729001 | Elucidating the host-pathogen interaction between human colorectal cells and invading Enterovirus 71 using transcriptomics profiling |
| Q40140935 | Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons |
| Q36491843 | Geldanamycin, a ligand of heat shock protein 90, inhibits the replication of herpes simplex virus type 1 in vitro |
| Q24305160 | Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo |
| Q33625030 | Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection |
| Q35531602 | Herpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation |
| Q36607105 | Herpes simplex virus 1 tropism for human sensory ganglion neurons in the severe combined immunodeficiency mouse model of neuropathogenesis |
| Q35223463 | Human cancer cells have specifically lost the ability to induce the synergistic state caused by tumor necrosis factor plus interferon-beta |
| Q40229512 | Hyper-activated IRF-1 and STAT1 contribute to enhanced interferon stimulated gene (ISG) expression by interferon alpha and gamma co-treatment in human hepatoma cells |
| Q30840932 | Immune Escape via a Transient Gene Expression Program Enables Productive Replication of a Latent Pathogen |
| Q37415387 | Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure |
| Q36298634 | Incorporation of the B18R gene of vaccinia virus into an oncolytic herpes simplex virus improves antitumor activity |
| Q27485444 | Independent and Cooperative Antiviral Actions of Beta Interferon and Gamma Interferon against Herpes Simplex Virus Replication in Primary Human Fibroblasts |
| Q40416418 | Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon |
| Q40480803 | Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium. |
| Q97521212 | Inhibition of African Swine Fever Virus Replication by Porcine Type I and Type II Interferons |
| Q35260078 | Innate and adaptive immune responses to herpes simplex virus |
| Q35627416 | Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication. |
| Q33711923 | Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro |
| Q40505474 | Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). |
| Q41744581 | Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients |
| Q35220908 | Interferon-gamma, macrophages, and virus spread after HSV-1 injection |
| Q24651415 | Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication |
| Q37093565 | Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. |
| Q35087776 | Lethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simplex virus 1. |
| Q24815062 | Macrophages and cytokines in the early defence against herpes simplex virus |
| Q85054677 | Novel 4,5-dihydro-thiazinogeldanamycin in a gdmP mutant strain of Streptomyces hygroscopicus 17997 |
| Q35783093 | Oligoadenylate synthetase/protein kinase R pathways and alphabeta TCR+ T cells are required for adenovirus vector: IFN-gamma inhibition of herpes simplex virus-1 in cornea |
| Q91776793 | Optimizing oncolytic virotherapy in cancer treatment |
| Q42227801 | Packaging, amplification, and appraisal of the recombinant tumor-selective type I herpes simplex virus carrying GALV.fus gene |
| Q24801970 | Permissive human cytomegalovirus infection of a first trimester extravillous cytotrophoblast cell line |
| Q34850941 | Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functions |
| Q37492787 | Re-evaluating natural resistance to herpes simplex virus type 1. |
| Q24814677 | Re-evaluating the role of natural killer cells in innate resistance to herpes simplex virus type 1 |
| Q36939781 | Recognition of herpesviruses by the innate immune system |
| Q42064424 | STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts |
| Q39103869 | Signal transducer and activator of transcription 3 (Stat3) regulates host defense and protects mice against herpes simplex virus-1 (HSV-1) infection |
| Q40530772 | Suppression of herpes simplex virus 1 in MDBK cells via the interferon pathway |
| Q57295082 | Synergistic effect of ribavirin and vaccine for protection of early infection stage of foot-and-mouth disease |
| Q40220756 | Synergistic inhibition of SARS-coronavirus replication by type I and type II IFN. |
| Q24802610 | Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma |
| Q34722791 | TRIM11 negatively regulates IFNβ production and antiviral activity by targeting TBK1 |
| Q60031594 | The Scorpion Venom Peptide Smp76 Inhibits Viral Infection by Regulating Type-I Interferon Response |
| Q43215263 | The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts |
| Q36671106 | The challenge of developing a herpes simplex virus 2 vaccine |
| Q34885415 | The synergistic effect of IFN-alpha and IFN-gamma against HSV-2 replication in Vero cells is not interfered by the plant antiviral 1-cinnamoyl-3, 11-dihydroxymeliacarpin |
| Q34254496 | Toll-like receptor (TLR) 2 and TLR9 expressed in trigeminal ganglia are critical to viral control during herpes simplex virus 1 infection |
| Q42145014 | Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2. |
| Q37205363 | Tumor necrosis factor and interferon: cytokines in harmony |
| Q35689581 | Two microRNAs encoded within the bovine herpesvirus 1 latency-related gene promote cell survival by interacting with RIG-I and stimulating NF-κB-dependent transcription and beta interferon signaling pathways |
| Q38281570 | Type I IFN family members: similarity, differences and interaction |
| Q36559565 | hsp70 and a novel axis of type I interferon-dependent antiviral immunity in the measles virus-infected brain |
Search more.